The study also confirmed that exercise induces endogenous MOTS-c production in human skeletal muscle, establishing a bidirectional relationship between MOTS-c and physical activity (Reynolds JC et al., Nat Commun
Benefits Appetite suppressant Promotes sensation of fullness Can be taken alone, or in combination with GLP1, to promote weight loss Currently in Phase III clinical trial (RENEW2) evaluating its effect on obesity and diabetes as monotherapy Currently in Phase III clinical trial (REDEFINE3) evaluating its effect on cardiovascular health, when combined with Semaglutide Dosing Subcutnaeous 0.6 mg 4.8 mg Once a Week Any time of day SEMAGLUTIDE Synthetic polypeptide
de Breij, A., Riool, M., Cordfunke, R.A., Malanovic, N., de Boer, L., Koning, R.I., et al., Sci
Our compounds are manufactured and handled with strict quality protocols to support consistency and reliability in research environments
(PubMed) Williams AL, Girard C, Jui D, Sabina A, Katz DL